Radiotherapy for postoperative persistent cancer of the head and neck.
D000328:Adult; D000368:Aged; D003528:Carcinoma, Adenoid Cystic / Q000532:radiotherapy*; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy*; D004428:Ear Neoplasms / Q000532:radiotherapy; D005005:Ethmoid Sinus; D005260:Female; D006257:Head; D006258:Head and Neck Neoplasms / Q000532:radiotherapy*; D006801:Humans; D007822:Laryngeal Neoplasms / Q000532:radiotherapy; D008048:Lip Neoplasms / Q000532:radiotherapy; D008223:Lymphoma / Q000532:radiotherapy*; D008297:Male; D008722:Methods; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local / Q000532:radiotherapy*; D009369:Neoplasms / Q000532:radiotherapy*; D009669:Nose Neoplasms / Q000532:radiotherapy; D010255:Paranasal Sinus Neoplasms / Q000532:radiotherapy; D011879:Radiotherapy Dosage; D011882:Radiotherapy, High-Energy; D012468:Salivary Gland Neoplasms / Q000532:radiotherapy; D013997:Time Factors; D014827:Vocal Cords